Intrathecal therapy with rituximab in central nervous system involvement of post-transplant lymphoproliferative disorder

Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid

(2011) Timi Martelius et al.   BMC INFECTIOUS DISEASES

Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant

(2011) Denise K. Bonney et al.   PEDIATRIC BLOOD & CANCER

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges

(2011) N.A. Kittan et al.   Transplant Infectious Disease

EBV-Associated Leukoencephalopathy with Late Onset of Central Nervous System Lymphoma in a Kidney Transplant Recipient

(2010) A. Vaglio et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Primary central nervous system post-transplantation lymphoproliferative disorder

(2010) Robert Cavaliere et al.   CANCER

A case of Epstein-Barr virus associated post-transplant lymphoproliferative disorder with CNS involvement: pathological findings at both biopsy and autopsy

(2010) Makiko Suzuki et al.   NEUROPATHOLOGY

Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation

(2009) Y. Aisa et al.   Transplant Infectious Disease

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

(2008) J Styczynski et al.   BONE MARROW TRANSPLANTATION

Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy

(2008) José Carlos Jaime-Pérez et al.   BRITISH JOURNAL OF HAEMATOLOGY

Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

(2008) Chun-Yu Liu et al.   LEUKEMIA & LYMPHOMA

Successful Treatment of EBV PTLD with CNS Lymphomas with the Monoclonal Anti-CD20 Antibody Rituximab

(2008) Lambros Kordelas et al.   Oncology Research and Treatment

Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system

(2007) Gretha van de Glind et al.   PEDIATRIC BLOOD & CANCER